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Abstract
Background: Consensus on how to adequately measure patient satisfaction with health care is limited,
and has led to the development of many questionnaires with various methodological problems. The
objective of this study was to develop a liver disease- and care-specific patient satisfaction instrument on
the basis of previously tested methodology in patient satisfaction measurement, the so called QUOTE-
series: Quality Of health care services Through the patients' Eyes. QUOTE methodology aims to
standardise the measurement of satisfaction as the discrepancy between patients' needs, and the extent
to which these needs are being met.
Methods: As part of the QUOTE methodology routine, 11 Patients with chronic liver disease from the
Erasmus MC (Rotterdam, the Netherlands) participated in focus-group meetings on patient satisfaction
with the provided service at the outpatient hepatology clinic. Twenty-eight other patients were invited to
rank the items generated during the focus-group meetings according to importance. With this information,
the QUOTE-Liver was constructed. Face validity, construct validity, content validity, and reliability of the
newly developed questionnaire were assessed in a test sample of 152 patients with chronic liver disease.
Results: Two liver-disease specific, and the 18 items ranked as most important were included in the
QUOTE-Liver. Face validity and content validity were acceptable: neither patients (n = 152) nor
psychologists (n = 3) or a hepatologist suggested any extra items to be included. Construct validity was
good: the overall score correlated significantly with the Visual Analogue Scale (VAS) measuring overall
satisfaction (r = 0.69, p < 0.01). The reliability of the QUOTE-Liver was excellent (α = 0.90).
Conclusion: The QUOTE-Liver is an easy to complete instrument based on standardized state-of-the-
art satisfaction measurement methodology. Preliminary evidence for its validity and reliability was
demonstrated. The QUOTE-liver covers those aspects of satisfaction that CLD patients consider to be
important when visiting the outpatient department of hepatology. Even though further substantiating of
the favourable psychometric findings is desirable, it seems to be a useful instrument that can be used to
identify those aspects of care that need improvement in order to optimise the provision of health care for
patients with chronic liver disease.
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As liver disease is often chronic and progressive, frequent
monitoring of medication and progression of the disease
is necessary. Therefore, besides the quality of the medical
therapy, good quality of care is important to these patients
as they frequently interact with their physicians. Besides
good medical therapy, good quality of care determines
patient satisfaction. Patient satisfaction, in turn, has
proven to be important in compliance with treatment,
seeking medical advice and maintenance of a continuous
relationship with a physician [1,2]. Also, patient satisfac-
tion and quality of care are increasingly of interest to
health insurance companies or health maintenance
organisations that wish to negotiate prices when purchas-
ing health care.
Although studies on quality of care/patient satisfaction
are numerous, there has until recently been no consensus
on how to measure this concept. Most researchers have
unjustly dealt with patient satisfaction as an easy concept
to measure [3]. This has led to several methodological
problems in this field of research. First, the items of the
questionnaires or inventories of patients' experiences,
have been generated by health care professionals rather
than patients, even though several studies have demon-
strated that patients' and health care professionals' views
about important aspects of satisfaction are often quite dif-
ferent [4-6]. Secondly, there has been a lack of disease-
and care-specific items [7]. Finally, when asking patients
to answer on a Visual Analogue Scale (VAS) the question
"how satisfied are you", 90% tends to be satisfied in [7-9].
This may not be realistic, since a previous study has shown
that many patients who reported being satisfied with the
care they received, also indicated numerous problems
with this same care [10]. Furthermore, this single item
question does not give any indication of what needs to be
changed when patients are not satisfied.
The lack of consensus on adequate measurement of
patient satisfaction has led to a proliferation of question-
naires with inadequate measurement properties. A meta-
analysis [3] in which 195 articles about patient satisfac-
tion were screened, revealed that the instruments used to
measure patient satisfaction were different in almost every
study. Data on psychometric properties of the instru-
ments, including their validity and reliability were scarce.
A study on the use of patient satisfaction instruments by
leading academic medical centres in the United States of
America showed little standardization of the instruments
currently being used at these centres, particularly for out-
patient care [11].
The existence of so many different 'satisfaction' instru-
ments and the lack of data on their reliability and validity
does not only cast doubt on the soundness of the instru-
ments, but also makes comparisons of studies impossible
and conclusions drawn from studies implausible. For
these reasons, the Netherlands Institute for Health Serv-
ices Research (NIVEL) has developed a methodology pro-
tocol to develop a standardized series of questionnaires
measuring Quality of Care Through the Patient's Eyes
(QUOTE), based on market research theory [12], which
asserts that consumer satisfaction should be measured by
looking at the discrepancy between what consumers
need/expect and what they actually receive [13]. QUOTE
instruments are now available for a variety of diseases,
such as HIV, IBD, and rheumatism. QUOTE instruments
consist of two parts: the weight (importance) patients
assign to different aspects of health care, second, patients'
experiences with health care (performance). From the
combined effect of importance and performance, the
quality index can be obtained [14].
The aim of this study was to develop a liver disease- and
care-specific version of the QUOTE, called the QUOTE-
Liver, which measures quality of care/patient satisfaction
in patients with chronic liver disease (CLD). The need for
a liver disease- and care-specific instrument was grounded
in the fact that CLD affects many people worldwide (560
million people are infected with the hepatitis B or C virus
[15]), and alcohol-induced end-stage liver disease forms
the second most important reason for liver transplanta-
tion in the United States [16]. CLD is a serious disease that
is associated with significant physical and psychological
symptoms such as impaired cognition, hepatic coma,
fluid in the abdomen, abdominal pain, joint pain, fatigue,
depression and anxiety [17-23]. The development of the
QUOTE-Liver was undertaken in order to deal with all
aforementioned methodological issues by asking patients
rather than health care professionals to define important
aspects of care, by including disease- and care-specific
items, by focussing on the discrepancy between individual
patients' needs and whether these needs have been met,
and having been developed along the lines of a series of
similar questionnaires which makes comparison between
patient populations possible.
Methods
In order to develop the QUOTE-Liver we followed the
QUOTE protocol as described by the Netherlands Insti-
tute of Health Services Research (NIVEL, Utrecht, the
Netherlands) [24].
Study population
All patients suffering from chronic liver disease (CLD) vis-
iting the outpatient department of Hepatology of the Eras-
mus Medical Centre in Rotterdam, which is a specialized
centre for chronic liver disease in the Netherlands, during
the first three months of 2004 were invited to participate
in the development of the QUOTE-Liver by mail. PatientsPage 2 of 7
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letter and invited to contact the researcher if they wanted
additional information and if they were considering par-
ticipating in the study. The phases of the study were done
consecutively, each time approaching a new patient sam-
ple. Patients were included in each phase of the study on
a first-come first-serve basis. Consequently, no informa-
tion is available on those patients who did not want to
take part in the study. Patients who were willing to partic-
ipate were contacted by the researcher, who provided
them with verbal and additional written information. All
participants completed an informed consent form. No
incentives for participating in the study were given. Travel
expenses of the patients participating in the focus group
discussions were covered. The study protocol was in
accordance with the ethical guidelines of the modified
1975 Declaration of Helsinki. Since patients were invited
to participate in one part of the study only, and since the
study did not include invasive questions, ethical approval
was not necessary under Dutch regulations.
Part one: Focus groups
Focus groups were first mentioned as a market research
technique in the 1920's [25,26]. They are an efficient
means to obtain data on opinions and attitudes. Focus
groups are qualitative interviews with a small number of
people. Unlike one-on-one interviews, focus groups gen-
erate information through group discussion, which
besides information about what people think, gives
insight in why people think the way they do. For good
results, just a few focus groups are sufficient, as data
become saturated and little new information emerges
after the first few groups [27].
The purpose of the focus groups in this study was for
patients to generate a list of relevant care aspects at the
outpatient department of Hepatology of the Erasmus MC.
Three focus group meetings were organized at the Eras-
mus MC (Rotterdam, the Netherlands), in which 11
patients participated (table 1). During the focus group
meetings, patients were asked to name all aspects of their
visit to the outpatient department of Hepatology that
were important to them. Meetings lasted from 70 to 90
minutes. Two researchers, one psychologist and one expe-
rienced psychotherapist who could resolve any arising
emotional issues, conducted the focus groups.
Part two: Item Ranking
The patients ranked the items to create an order of impor-
tance in the aspects named in the focus group meetings
[28]. For this ranking exercise, which took place at the out-
patient department of Hepatology of the Erasmus MC, all
aspects mentioned during the focus group meetings were
written on separate cards, which patients were asked to
divide over five piles, ranging from "most important (1)"
to "least important (5)". The piles had to be of nearly
equal size in order to force patients to make a choice. To
make sure that no aspects had been missed during the
focus group meetings, the patients were asked at this stage
whether they thought any important items were missing.
The item-ranking task was carried out by one researcher.
Part three: Selection of items
The QUOTE protocol has no strict guidelines regarding
the number of items to be included. Because we wanted
an easy to administer questionnaire, we (the authors)
opted for a 20-item questionnaire, which is in the lowest
range of item numbers of the already existing QUOTE
instruments like the QUOTE-IBD (23 items), QUOTE-
HIV (27 items), QUOTE-Occupational Therapy short ver-
sion (23 or 12 items). Since we were interested in the
items that were most important to patients, we decided to
follow the preferences of patients closely, rather than to
chose items belonging to a priori determined aspects of
care such as accessibility, waiting room area, etc. Because
QUOTE questionnaires are disease- and care-specific, dis-
ease- and care-specific items were also included.
Scoring and interpretation of scores
All QUOTE questionnaires, and thus also the final
QUOTE-Liver, consist of two parts. The questioning style
is deliberately repetitious as it has been reported that this
ensures patients' understanding. In part one, importance
of the 20 items is measured. The fact that ordinary Likert
scales tend to be highly skewed towards the 'important'
dimension was solved by providing 4-point response
Table 1: Demographic and clinical characteristics of the patient population included in the development of the questionnaire.
Focus Groups Item Ordering Validation study
Total number of patients (n) 11 27 152
Male (n, %) 6 (55) 11 (39) 81 (53)
Age (mean, range) 48.3 (18–75) 50.7 (21–74) 46.7 (19–75)
Liver disease (n,%)
Post-transplantation 5 (45) 5 (18) 24 (16)
Viral Hepatitis 4 (37) 10 (36) 72 (47)
Cholestatic Liver Disease 2 (18) 3 (1) 40 (26)
Other 0 (0) 10 (36) 16 (10)Page 3 of 7
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6 = 'important', 10 = 'very important'), which proved to be
a workable solution [14]. In part two, performance on
those same 20 items is measured. Patients are asked what
actually happened during the consultation. They can rate
items on a four-point scale ranging: 'no' (score = 1), 'not
really' (0.67), 'mostly yes' (0.33), and 'yes' (0). The
QUOTE protocol defines the aspects of care that need
improvement when more than 10% of patients are dissat-
isfied, reflected by a total score of <9.0 (range is 0 – 10),
computed by the formula: 10 – importance × perform-
ance [29]. For the QUOTE-Liver we have followed this
QUOTE family approach to item scaling.
Part four: Validation study
Psychometric methods
Principal component analysis was run to explore factors
within the questionnaire.
Reliability of the QUOTE-Liver was measured by comput-
ing the internal consistency of the items and the item-total
correlations using the reliability analysis in SPSS 11.0.
Face validity, i.e the extent to which experts judge the
instrument to measure the intended concept, was deter-
mined by presenting it to 152 patients with chronic liver
disease, three psychologists and a hepatologist. To guar-
antee correct measurement of the concept (quality of care
from patients' perspective), construct and content validity
were measured. Construct validity, i.e. the degree to which
an instrument measures the theoretical construct it is
intended to measure, was measured by computing Pear-
son correlations between a Visual Analogue Scale (VAS),
and the total quality impact score of the QUOTE-Liver.
The VAS consisted of a horizontal line on which patients
had to indicate by means of a cross, to what extent they
agreed (no, definitely not – yes, definitely) with the fol-
lowing question: 'Would you recommend a consultation
at this outpatient department to your best friend if he/she
was in the same circumstances?" Scores were calculated as
percentages of the scale, with 0 indicating total disagree-
ment, and 100 indicating perfect agreement. To assess con-
tent validity, patients were asked to indicate which other
items should be included in the QUOTE-Liver. A
researcher who was present while patients completed the
questionnaire explored the feasibility by looking at the
time it took for patients to complete the questionnaire, by
reporting patients who failed to complete the question-
naire, and by noting patients' questions regarding the
instructions and/or items. In addition, patients were
asked whether they had understood the questions, if they
thought completing the questionnaire was easy or diffi-
cult, and what they thought of the completion time.
Results
Patients in the study
11 patients with CLD participated in the focus group
meetings, and 28 patients participated in the item-ranking
task. 152 patients completed the QUOTE-Liver for valida-
tion purposes. The demographic and clinical characteris-
tics of these patients are shown in Table 1.
Part one: Focus groups
The focus group meetings generated 121 partly overlap-
ping aspects that patients found important when visiting
the department of Hepatology. These were converted into
70 distinct items. Most items (30) concerned competence
and social skills of the physician. 16 items concerned the
waiting room area, nine items referred to assisting person-
nel and making appointments, eight items concerned
availability of information, two were about venipuncture
and five concerned accessibility of the hospital.
Part two: Item ranking
The mean importance scores of the 70 items ranged from
4.65 for competence of the physician to 1.38 for presence
of a cloakroom at the outpatient department. Two dis-
ease- and care-specific items were mentioned: "the veni-
puncture nurses are skilled" and "I don't have to wait long
for venipuncture". No items were mentioned when
patients were asked if any important items were missing.
Part three: Selection of items
Two disease- and care-specific items were included in the
QUOTE-Liver: 'waiting time for venipuncture' and 'skills
of the venipuncture nurses'. Besides these two items, the
18 most important items following from the item-ranking
task were included. The importance scores did not show a
clear difference between important and less important
items. Rather, scores for importance decreased gradually
(score of item 18 = 3.88, score of item 19 = 3.81). Conse-
quently, the decision to include 20 items in the QUOTE-
Liver was made to coincide with the number of items of
other QUOTE-instruments. Table 2 shows all items
included in the QUOTE-Liver. The scores presented in this
table were derived from the validation study conducted
with 152 patients. In that study, the average importance
and performance scores were computed using the Likert
scales, resulting in a range varying from 0 to 10 for the
importance scores and a range of 0 to 1 for the perform-
ance scores. There were no missing data.
Part four: Validation study
Data analysis
Principal component analysis yielded four factors. 17
items concerning interaction/contact with the physician
loaded high on factor one. One disease- and care-specific
item ("How important is it for you that the waiting time
for venipuncture is short") loaded high on factor two. ThePage 4 of 7
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for you that the venipuncture nurses are skilled" loaded
high on factor three. One item ("How important is it to
you that the doctor that you visit today is knowledgea-
ble") loaded high on factor four.
The internal consistency of the overall QUOTE-Liver was
excellent (α = 0.90). The item-total correlations of the 17
items concerning interaction with the physician ranged
from 0.40 to 0.71 (alpha if item deleted = 0.89 – 0.90).
The item-total correlation of the two disease- and care-
specific items and of the first item concerning the physi-
cian's knowledge were 0.08, 0.37 and 0.39 respectively
(alpha if item deleted = 0.90–0.91). Face validity was
excellent: all patients (n = 152) in the validation study,
and three psychologists and a hepatologist agreed that the
items of the QUOTE-Liver adequately reflected the most
important aspects of care for CLD patients. Construct
validity, as measured by the correlation between the VAS
measuring overall satisfaction and the total score on the
QUOTE Liver was substantial (r = 0.69; p < 0.01). Content
validity was also good: none of the 152 patients in the val-
idation study suggested new items to be included. Feasi-
bility was established as all patients in the validation
study completed the QUOTE-Liver quickly (average time
of 1.5 minutes), and understood the items.
Discussion
In the present study, we have developed an easy to com-
plete, self-administered liver disease- and care-specific
questionnaire that measures quality of care through the
patient's eyes (QUOTE-Liver). Preliminary evidence for its
validity and reliability was demonstrated. The QUOTE-
Liver was developed using a protocol that has recently
been applied to develop a series of disease- and care-spe-
cific patient satisfaction instruments (QUOTES) [14]. The
QUOTE-Liver consists of two liver disease- and care-spe-
cific items, and the 18 most important items out of 70
defined by 28 patients with chronic liver disease. Seven-
teen items concerned interaction/contact with the physi-
cian. Three other items did not correlate with the 17 items
on interaction/contact with the physician. These items
were added to the questionnaire since they had clear the-
oretical and clinical relevance and added to the disease-
specific nature of the QUOTE-Liver questionnaire. Future
research would do well to further look into these three
items and further elaborate on them.
Table 2: Items included in the QUOTE-Liver and scores of 152 Dutch patients with chronic liver disease.
Importance Score Performance Score Quality Impact Score
How important is it to you that the doctor that you visit today...
1 Is knowledgeable 9.46 0.04 9.60
2 Takes time to discuss emotional issues 6.58 0.15 9.21
3 Takes you seriously 9.00 0.04 9.66
4 Makes you feel safe 8.09 0.07 9.50
5 Believes what you say 8.50 0.05 9.57
6 Takes enough time for you 8.05 0.07 9.45
7 Is friendly 7.53 0.03 9.81
8 Is open 8.47 0.05 9.58
9 Listens to you 8.58 0.05 9.59
10 Answers all of your questions 8.67 0.06 9.51
11 Gives you enough information about your disease/treatment 9.01 0.08 9.31
12 Gives you a say in your treatment 7.76 0.10 9.24
13 Answers your questions clearly 8.56 0.07 9.45
14 Gives you medical/technical information about your disease when you ask 
for it
8.41 0.05 9.62
15 Gives enough explanation about your medication and possible side effects 8.24 0.05 9.56
16 Refers you well when you present with complaints that are not liver disease-
related
8.03 0.04 9.61
17 Takes action quickly 8.96 0.04 9.62
How important is it for you that...
18 You can tell your doctor what's on your mind 7.15 0.05 9.72
19 The venipuncture nurses are skilled 7.78 0.05 9.54
20 The waiting time for venipuncture is short 5.47 0.12 9.12
The QUOTE-Liver consists of the two disease- and care-specific items (19 and 20) and the 18 most important items for quality of care as measured 
in a population of chronic liver patients. The questioning style is deliberately repetitious, as it has been reported that this ensures patients' 
understanding. Importance scores can range from 0–10, performance scores can range from 0–1. A 'quality impact score' of <9.0 indicates that 
more than the usual 10% of the patients are dissatisfied with the particular aspect of care.Page 5 of 7
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Liver concerned aspects related to the physician. Appar-
ently, other aspects of care such as accessibility, coopera-
tion with other health care workers, and accommodation
are of lesser importance to patients with chronic liver dis-
ease. This may explain the fact that no dissatisfaction, as
shown by a score below 9.0, was established. Indeed,
other QUOTE instruments found dissatisfaction on items
pertaining to accessibility (by telephone) [8,29-32], doc-
tors' and nurses' psychosocial approach [29,30,32], infor-
mation [8,29-32], cooperation with other health care
workers [30-32], privacy [8,32], and patient authority
[8,30], rather than medical competence, contact, and
communication, with the exception of 'information'.
Exclusion of these multiple aspects in the development of
the QUOTE-Liver was chosen for deliberately since these
were of lesser importance to patients with chronic liver
disease.
The high satisfaction scores obtained by the QUOTE-Liver
in the present study may have been a result of the high
standards of care at the specialized liver center of the Eras-
mus MC. However, these high scores cast doubt on its
ability to detect change over time in the same group
receiving an intervention, or changes between groups
receiving different interventions. As the instrument could
potentially be important for use in intervention studies,
further testing of the QUOTE-Liver in its current form,
preferably in an experimental setting where "bad" care is
delivered purposefully, is needed in order to draw firmer
conclusions on its sensitivity. Another way to assess the
sensitivity of the QUOTE-Liver may be to administer it in
two different settings, a specialized setting and a less spe-
cialized setting. A before and after study, where some
aspect of care has been changed, is also a possibility that
should be explored.
The method of patient selection used in this study may
have caused bias. Even though the most important forms
of chronic liver disease (HBV, HCV and cholestatic liver
disease) were represented in the patient sample used in
the present study, and even though the average age was
representative of the overall population of CLD patients
[17], no information was available of patients who did
not want to participate. Future studies should register
characteristics of non-participants.
Future studies should also assess the reproducibility of the
QUOTE-Liver in terms of test-retest reliability. In addi-
tion, other ways should be explored to assess the construct
validity of the QUOTE-Liver. A VAS measuring satisfac-
tion was chosen since no adequate alternative was availa-
ble at the time of the study. Measuring satisfaction by
means of a VAS is relatively crude and possibly influences
the subsequent construct validity for which it was used.
Future studies could use the generic Dutch version of the
QUOTE, which is now available, to assess construct valid-
ity.
A possible limitation of QUOTE instruments in general
that has so far never been mentioned, is that some
patients may be reluctant to say "no" (e.g. no, my physi-
cian did not discuss emotional problems) as it may reflect
badly on the physician. Indeed, some patients in our
study expressed a need for an answering category 'not rel-
evant' for certain items of part two of the QUOTE-Liver.
This should certainly be considered, as it will probably
increase patient participation without compromising the
scoring of the instrument.
Conclusion
In conclusion, the QUOTE-Liver is an easy to complete
instrument to assess liver patients' satisfaction with health
care at an outpatient department, with evidence of good
validity and reliability. The high satisfaction scores that
the QUOTE-Liver produced in our validation study may
be a result of the items included in the questionnaire,
which mostly address physician competence and social
behavior. As long as physicians' treatment and communi-
cation are good, high scores are to be expected. Further
studies are needed to test the responsiveness and general-
izability of the QUOTE-Liver to other linguistic and cul-
tural settings.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
JJG: Has been involved in design of the study, data collec-
tion, statistical analyses and drafting of the manuscript.
A–SED: has made substantial contributions to interpreta-
tion of data and has been involved in drafting the manu-
script. JJVB: has been involved in revising the intellectual
content. RAdM: has been involved in data collection, and
revision of the intellectual content. All authors have read
and approved the final manuscript.
Acknowledgements
The authors would like to thank Dr. H.J. Sixma from the Netherlands Insti-
tute for Health Services Research for his valuable assistance with the devel-
opment of the QUOTE-Liver.
References
1. Larsen DE, Rootman I: Physician role performance and patient
satisfaction.  Soc Sci Med 1976, 10:29-32.
2. Schmidt CM: Patient satisfaction.  Clinical perspectives in gastroenter-
ology 1999, november/december:324-328.
3. Sitzia J: How valid and reliable are patient satisfaction data?
An analysis of 195 studies.  Int J Qual Health Care 1999,
11:319-328.
4. Laine C, Davidoff F, Lewis CE, Nelson EC, Nelson E, Kessler RC, Del-
banco TL: Important elements of outpatient care: a compari-
son of patients' and physicians' opinions.  Ann Intern Med 1996,
125:640-645.Page 6 of 7
(page number not for citation purposes)
BMC Gastroenterology 2008, 8:25 http://www.biomedcentral.com/1471-230X/8/25Publish with BioMed Central   and  every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
5. Lebow JL: Consumer assessments of the quality of medical
care.  Med Care 1974, 12:328-337.
6. Weaver MJ, Ow CL, Walker DJ, Degenhardt EF: A questionnaire
for patients' evaluations of their physicians' humanistic
behaviors.  J Gen Intern Med 1993, 8:135-139.
7. van Campen C, Sixma H, Friele RD, Kerssens JJ, Peters L: Quality of
care and patient satisfaction: a review of measuring instru-
ments.  Med Care Res Rev 1995, 52:109-133.
8. van Campen C, Sixma HJ, Kerssens JJ, Peters L: Assessing noninsti-
tutionalized asthma and COPD patients' priorities and per-
ceptions of quality of health care: the development of the
QUOTE-CNSLD instrument.  J Asthma 1997, 34:531-538.
9. Williams B: Patient satisfaction: a valid concept?  Soc Sci Med
1994, 38:509-516.
10. Jenkinson C, Coulter A, Bruster S, Richards N, Chandola T:
Patients' experiences and satisfaction with health care:
results of a questionnaire study of specific aspects of care.
Qual Saf Health Care 2002, 11:335-339.
11. Dawn AG, Lee PP: Patient satisfaction instruments used at aca-
demic medical centers: results of a survey.  Am J Med Qual 2003,
18:265-269.
12. Parasuraman A, Zeithaml VA, L. B: A conceptual model of service
quality and its implications for the future research.  Journal of
Marketing 1985, 49:41-50.
13. Murray CJ, Kawabata K, Valentine N: People's experience versus
people's expectations.  Health Aff (Millwood) 2001, 20:21-24.
14. Sixma HJ, Kerssens JJ, Campen CV, Peters L: Quality of care from
the patients' perspective: from theoretical concept to a new
measuring instrument.  Health Expect 1998, 1:82-95.
15. 2006 [http://www.epidemic.org].
16. Mandayam S, Jamal MM, Mogan TR: Epidemiology of alcoholic
liver disease.  Semin Liver Dis 2004, 24:217-232.
17. Gutteling JJ, de Man RA, van der Plas SM, Schalm SW, Busschbach JJ,
Darlington ASE: Determinants of quality of life in chronic liver
patients.  Aliment Pharmacol Ther 2006, 23:1629-1635.
18. Bayliss MS, Gandek B, Bungay KM, Sugano D, Hsu MA, Ware JE Jr.: A
questionnaire to assess the generic and disease-specific
health outcomes of patients with chronic hepatitis C.  Qual
Life Res 1998, 7:39-55.
19. Gralnek IM, Hays RD, Kilbourne A, Rosen HR, Keeffe EB, Artinian L,
Kim S, Lazarovici D, Jensen DM, Busuttil RW, Martin P: Develop-
ment and evaluation of the Liver Disease Quality of Life
instrument in persons with advanced, chronic liver disease--
the LDQOL 1.0.  Am J Gastroenterol 2000, 95:3552-3565.
20. van der Plas SM, Hansen BE, de Boer JB, Stijnen T, Passchier J, de Man
RA, Schalm SW: The Liver Disease Symptom Index 2.0; valida-
tion of a disease-specific questionnaire.  Qual Life Res 2004,
13:1469-1481.
21. Unal G, de Boer JB, Borsboom GJ, Brouwer JT, Essink-Bot M, de Man
RA: A psychometric comparison of health-related quality of
life measures in chronic liver disease.  J Clin Epidemiol 2001,
54:587-596.
22. Younossi ZM, Guyatt G: Quality-of-life assessments and chronic
liver disease.  Am J Gastroenterol 1998, 93:1037-1041.
23. Younossi ZM, Guyatt G, Kiwi M, Boparai N, King D: Development
of a disease specific questionnaire to measure health related
quality of life in patients with chronic liver disease.  Gut 1999,
45:295-300.
24. van Nispen RMA, Sixma HJ, Kerkstra A: Kwaliteit van indicati-
estelling door RIO's vanuit cliëntenperspectief.  Edited by:
NIVEL . Utrecht, ; 2002:81. 
25. Bogardus ES: The group interview.  Journal of applied sociology 1926,
10:372-382.
26. Kitzinger J: The methodology of focus groups: the importance
of interaction between research participants.  Sociology of
health & illness 2001, 16:103-121.
27. Morgan DL: Focus groups.  Annual review of sociology 1996,
22:129-152.
28. Sixma H, Calnan S, Calnan M, Groenewegen PP: User involvement
in measuring serivce quality of local authority occupational
therapy services; a new approach.  International journal of con-
sumer studies 2001, 25:150-159.
29. van der Eijk I, Sixma H, Smeets T, Veloso FT, Odes S, Montague S,
Fornaciari G, Moum B, Stockbrugger R, Russel M: Quality of health
care in inflammatory bowel disease: development of a relia-
ble questionnaire (QUOTE-IBD) and first results.  Am J Gastro-
enterol 2001, 96:3329-3336.
30. van Campen C, Sixma HJ, Kerssens JJ, Peters L, Rasker JJ: Assessing
patients' priorities and perceptions of the quality of health
care: the development of the QUOTE-Rheumatic-Patients
instrument.  Br J Rheumatol 1998, 37:362-368.
31. Nijkamp MD, Nuijts RM, Borne B, Webers CA, van der Horst F, Hen-
drikse F: Determinants of patient satisfaction after cataract
surgery in 3 settings.  J Cataract Refract Surg 2000, 26:1379-1388.
32. Hekkink CF, Sixma HJ, Wigersma L, Yzermans CJ, Van Der Meer JT,
Bindels PJ, Brinkman K, Danner SA: QUOTE-HIV: an instrument
for assessing quality of HIV care from the patients' perspec-
tive.  Qual Saf Health Care 2003, 12:188-193.
Pre-publication history
The pre-publication history for this paper can be accessed
here:
http://www.biomedcentral.com/1471-230X/8/25/pre
pubPage 7 of 7
(page number not for citation purposes)
